ArticleScientific reports2026
MAGC-DTI: modality-shared space and adaptive gated interactive cross-attention for drug-target interaction prediction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate drug-target interaction (DTI) prediction is crucial for drug repurposing and accelerating drug development. Although deep learning has advanced DTI prediction, existing methods struggle with two key challenges: (i) capturing complex hierarchical patterns in protein sequences, and (ii) enabling effective bidirectional information exchange between drug and protein modalities. We propose MAGC-DTI, an end-to-end cross-modal framework that integrates bidirectional information exchange into both feature extraction and fusion stages through three key innovations: (i) multi-scale attention aggregation (MSAA) for hierarchical protein pattern capture, (ii) adaptive gated interactive cross attention (AGICA) for context-aware cross-modal interaction, and (iii) multi-path residual classifier (MPRC) for modality-preserving fusion. Comprehensive evaluations on six benchmark datasets show that MAGC-DTI generally achieves favorable performance relative to seven state-of-the-art baselines, with competitive results in cold-start and cross-domain scenarios. The model also provides interpretable insights through attention visualization and case studies confirm the biological relevance of learned representations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.